Latest News

The panel members that have proposed the recommendations have found clinical utility for several genomic tests to guide clinical decision in women with early stage breast cancer.
Yet another alliance has been formed to help transform healthcare. This time 20 major employers, who represent 4 million employees and family members, have come together to improve how healthcare benefits are purchased.
Howard Springer Highlights Key Takeaways From Attending the ACO Coalition Live Meeting
Howard C. Springer, the administrative director of strategy for accountable care services for Swedish Medical Center in Seattle, explained that the benefit he got out of attending one of the past ACO and Emerging Healthcare Delivery Coalition was the knowledge from people who have been in the business for a while.
It is common for persons with mental illness to suffer comorbid conditions.
Many key guidelines regarding Medicaid and CHIP eligibility, enrollment, renewal, and cost-sharing policies have changed and the 14th annual 50-state survey from the Kaiser Family Foundation identified all the major changes that occurred in 2015.
The ads will be targeted at about 7000 "influencers" including lawmakers who could control whether drug prices are regulated. Many have called for Medicare to gain the right to negotiate drug prices.
What we're reading, February 8, 2016: 12.7 million people signed up for Affordable Care Act coverage, but 30 million remain uninsured; HHS plans to continue to encourage Medicaid expansion; and report analyzes the effect of patient-centered medical homes on cost and quality.
Using data gathered from the National Ambulatory Medical Care Survey, the authors of a JAMA Internal Medicine study identified a significant decrease in PSA testing referrals by primary care physicians compared with urologists.
A quirk in California law means the law that Governor Jerry Brown signed with much fanfare last fall hasn't taken effect yet, even though its passage is having ripple effects.
A deeper understanding of the interdependencies among the patients, family caregivers, and service providers revealed that if general practice teams intervene early, they may be more likely meet patients’ needs in the end-of-life care process.
For HIV-positive patients, cost considerations take on added importance because of the expensive antiretroviral prescription medications. As such, assessing premiums alone may not provide an accurate measure of plan affordability for HIV-positive patients.
Elizabeth Mitchell Explains the Goals of NRHI's Total of Care Project
The Network for Regional Healthcare Improvement (NRHI) has been leading a project to measure and report on total cost of care across different regions, and the end result could inform payment change, care delivery design, and health policy, explained Elizabeth Mitchell, president and CEO of NRHI.
Dr Patrick Conway Explains the Proposed MSSP Changes
Patrick Conway, MD, MSc, deputy administrator for innovation and quality and chief medical officer at CMS, describes the proposed changes to the Medicare Shared Savings Program and how they will assist accountable care organizations transitioning to tracks with more risks.
The novel molecule lipegfilgrastim has been shown to be relatively equivalent to pegfilgrastim in the management of chemotherapy-induced neutropenia among patients with breast cancer.

From the Journals

To address the nationwide concern of costly immunotherapy agents, this article features health system inpatient and outpatient strategies that can help mitigate their costs.
Supporting, funding, and protecting the research and development of new medicines and new treatments is more critical, now than ever, to provide better treatments and better outcomes to all cancer patients.
Advances made in the field of immuno-oncology (I-O) in 2015 have greatly expanded our understanding of I-O and added more complexity to its value assessment.
Re-analysis of US Preventive Services Task Force colorectal cancer screening guidelines shows that every-3-year screening with multi-target sDNA could address poor performance of recommended annual testing.
The translation of immuno-oncology agents from the research to the practice arena may provide significant clinical benefit to patients with difficult-to-treat malignancies. The further development and marketing of these agents could escalate the discussion on care equity in a time of constrained resources.
Assessment of the timing of histologic and molecular testing indicates that testing occurred prior to treatment initiation for most patients with metastatic non–small cell lung cancer.
This article analyzes use of lumbar spine magnetic resonance imaging in a national sample of patients with low back pain.
At the annual meeting of the American Society of Hematology, physicians gathered to discuss the impact of alternate payment models on clinical practice.
A study presented at the 57th meeting of the American Society of Hematology finds that distance from the site of care could could adversely affect outcomes in children with acute lymphoblastic leukemia and acute myeloid leukemia.
x-button
Featured Content
Feature
Diabetes Compendium
Oncology Compendium
COPD Compendium
Reimbursement Compendium

Most Popular

AJMC Strategic Alliance

$vacMongoViewPlus$